Evaluation of posture, gait, turning, and different kind of transitions, are key components of the clinical evaluation of Parkinson's disease (PD). The aim of this study is to assess the feasibility of using accelerometers to classify early PD subjects (two evaluations over a 1-year follow-up) with respect to age-matched control subjects. Classifying PD subjects in an early stage would permit to obtain a tool able to follow the progression of the disease from the early phases till the last ones and to evaluate the efficacy of different treatments. Two functional tests were instrumented by a single accelerometer (quiet standing, Timed Up and Go test); such tests carry quantitative information about impairments in posture, gait, and transitio...
Purpose: To investigate the validity of the activPAL accelerometer against the criterion measure of ...
Parkinson's disease (PD) is a neurodegenerative disease inducing dystrophy of the motor system. Auto...
Background: Treatment plans for Parkinson’s disease (PD) are based on a disease stage scale, which i...
Evaluation of posture, gait, turning, and different kind of transitions, are key components of the c...
Posture analysis in quiet standing is a key component of the clinical evaluation of Parkinson’s dise...
Abstract: Objective: Gait may be a useful biomarker that can be objectively measured with wearable t...
Objective: To examine whether gait and postures can accurately be detected with a single small body-...
Evaluation of the locomotor function is important for several clinical applications (e.g. fall risk...
Objective: To examine whether gait and postures can accurately be detected with a single small body-...
none5The Timed Up and Go (TUG) is a widely used clinical test to assess mobility and fall risk in Pa...
Motor impairments are the prerequisite for the diagnosis in Parkinson’s disease (PD). The cardinal s...
In the last few years, the importance of measuring gait characteristics has increased tenfold due to...
The Timed Up and Go (TUG) test is a clinical test to assess mobility in Parkinson's disease (PD). It...
<div><p>Motor impairments are the prerequisite for the diagnosis in Parkinson's disease (PD). The ca...
It would be of both patients’ as well as clinicians’ interest, if diagnosis of Parkinson’s disease (...
Purpose: To investigate the validity of the activPAL accelerometer against the criterion measure of ...
Parkinson's disease (PD) is a neurodegenerative disease inducing dystrophy of the motor system. Auto...
Background: Treatment plans for Parkinson’s disease (PD) are based on a disease stage scale, which i...
Evaluation of posture, gait, turning, and different kind of transitions, are key components of the c...
Posture analysis in quiet standing is a key component of the clinical evaluation of Parkinson’s dise...
Abstract: Objective: Gait may be a useful biomarker that can be objectively measured with wearable t...
Objective: To examine whether gait and postures can accurately be detected with a single small body-...
Evaluation of the locomotor function is important for several clinical applications (e.g. fall risk...
Objective: To examine whether gait and postures can accurately be detected with a single small body-...
none5The Timed Up and Go (TUG) is a widely used clinical test to assess mobility and fall risk in Pa...
Motor impairments are the prerequisite for the diagnosis in Parkinson’s disease (PD). The cardinal s...
In the last few years, the importance of measuring gait characteristics has increased tenfold due to...
The Timed Up and Go (TUG) test is a clinical test to assess mobility in Parkinson's disease (PD). It...
<div><p>Motor impairments are the prerequisite for the diagnosis in Parkinson's disease (PD). The ca...
It would be of both patients’ as well as clinicians’ interest, if diagnosis of Parkinson’s disease (...
Purpose: To investigate the validity of the activPAL accelerometer against the criterion measure of ...
Parkinson's disease (PD) is a neurodegenerative disease inducing dystrophy of the motor system. Auto...
Background: Treatment plans for Parkinson’s disease (PD) are based on a disease stage scale, which i...